This is a common care study. A study for evaluating the quality of balloon inflation and stent application will be performed in 2D angiography alone in the control group and then by 2D and OCT angiography for the experimental group. The benefit could be an improvement in the results of revascularization of femoropopliteal lesions thanks to OCT which allows a 3D visualization of the arterial lumen.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
166
Femoropopliteal revascularization: ATL or ATL/stenting for TASC C/D lesions. Control group: only angiography 2D final control. Experimental group: angiography + OCT control
Insitut Coeur-Poumon, CHU
Lille, France
RECRUITINGPrimary patency rate at 1 year.
The permeability rate is defined by the echodoppler criteria: PVS\>2.4m/s or appearance of stenosis on the previously treated segment \>70%.
Time frame: at 12 months (+/- 2months)
Primary patency rate at 1 year.
Time frame: at 1month (+/- 10days), 6months (+/- 1month)
Target lesion revascularisation
corresponds to the occurrence of a re-intervention on the treated segment to maintain or restore permeability
Time frame: at 1month (+/- 10days), 6months (+/- 1month) and 12 months (+/- 2months)
Target vessel revascularisation
corresponds to the occurrence of a re-intervention on the previously treated artery, whatever the level, in order to maintain its permeability.
Time frame: at 1month (+/- 10days), 6months (+/- 1month) and 12 months (+/- 2months)
cost-effectiveness analyses
Cost-effectiveness analysis between 2 therapeutic strategies: The costs related to each strategy are calculated taking into account the direct and indirect costs.
Time frame: at 12 months (+/- 2months)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.